Overview

• Claire Reid, 49, began self-administering GLP-1 weight-loss injections from an online pharmacy after completing only a questionnaire and without medical supervision.
• She lost four stone in four months but developed severe dehydration, daily collapses and black urine, prompting her children to rush her to hospital.
• Doctors at Aberdeen Royal Infirmary treated her with an IV drip for a week and linked her collapse to the unsupervised GLP-1 therapy.
• Reid remains weak, struggles with appetite and hydration after stopping the injections and is publicly warning others against off-label use.
• Regulators have logged hundreds of adverse reports, including pancreatitis cases, and health officials are calling for stricter prescribing rules and public education.